Cancers originating from organs in the peritoneal cavity (e.g., ovarian, pancreatic, colorectal, gastric and liver) account for approximately 250,000 new cancer cases annually in the USA. Peritoneal ...

Uncertainty exists over whether hemodialysis or peritoneal dialysis is the modality associated with better survival in patients with end-stage renal disease. Mehrotra and colleagues have shown that ...

Please provide your email address to receive an email when new articles are posted on . The addition of intraperitoneal paclitaxel to systemic capecitabine and oxaliplatin appeared to benefit patients ...

Hyperthermic intraperitoneal chemotherapy (HIPEC) provides an important treatment option that can improve survival for some patients with advanced peritoneal cancer. Managing this disease — and ...

What do the Kidneys do? The kidneys work as a filtering unit for the blood in our bodies and help in excreting waste products from the blood stream. The kidney filters out waste products from the ...

One sixth of patients receiving dialysis in the UK manage their underlying chronic kidney disease using peritoneal dialysis. Although it is generally undertaken at home, non-specialist renal nurses ...

PPC is a type of cancer that starts in the peritoneal cavity in the abdomen, rather than cancer that has developed elsewhere in the body and spread to the peritoneum. Cancer that has started elsewhere ...

Impact of lung and heart dose on survival after radiotherapy for esophageal cancer. RAINFALL: A randomized, double-blind, placebo-controlled phase III study of cisplatin (Cis) plus capecitabine (Cape) ...

Since patients with peritoneal metastases often also have distant metastases in systemic organs, intravenous therapy is usually the standard of care. Multiple clinical studies have shown that adding ...